简体中文 | 繁體中文 | English

Quintiles 01

Quintiles, Health Kare Pharma International, Ramco Announce Joint Venture to Launch Commercial Services Company in Egypt

2010-09-30 14:22
  • zh_cn
  • zh_hant
  • en

 

Arrangement unites local market knowledge with global commercialization experience

RESEARCH TRIANGLE PARK, N.C. & CAIRO--(BUSINESS WIRE)--Quintiles, Health Kare Pharma International (HKPI), and Ramco Import and Export today announced the formation of a joint venture to provide specialized pharmaceutical contract sales force and sales promotion outsourcing services in Egypt.

Known as HKPI-JV, with principal offices in Cairo, the new company will help biopharmaceutical companies commercialize therapies in Egypt by recruiting, training and placing pharmaceutical sales representatives; forming and managing outsourced sales and medical marketing teams; and product marketing and sales forecasting. HKPI-JV will begin operations in Egypt during the fourth quarter of 2010.

“This joint venture unites solutions and expertise from three companies with proven track records of success to offer sophisticated services to customers with large portfolios and a need for our marketing expertise,” said Hossam Kamel, Managing Director of HKPI. “The alliance brings together deep local market knowledge with global commercialization expertise, along with existing stakeholder relationships and a network of regional contacts.”

“The JV is a new option for companies seeking improved performance through alternative sales and marketing models,” said Makram Mehany, founder of Global Napi Pharmaceuticals, the parent company of Ramco. “At Napi, we have more alliances with international companies than any other biopharma organization in Egypt. As more local biopharma companies seek outsourcing solutions for their portfolios, the joint venture provides flexibility, skilled expertise, efficient organizations, reputable partners and adherence to the highest standards of ethics.”

“We have allied with these biopharma companies to expand our commercial service offerings into a new market that is an attractive point of entry into the region,” said Rich Pilnik, Executive Vice President of Quintiles and President of Global Commercial Solutions. “The biopharma market in Egypt has tremendous growth potential and biopharma customers in the region now have a resource that brings the best of both local and global expertise to the table.”

About HKPI

Headquartered in Egypt, Health Kare Pharma International provides sales and marketing support for major local manufacturers. Led by Hossam Kamel, who previously headed several multinational pharmaceutical companies and the Pharma Organization, with wide experience in the Egyptian market, United Kingdom and the United States, HKPI team members have extensive, recent multinational experience and have held leading positions in the pharmaceutical industry.

About Ramco

Ramco Import and Export Co. is an affiliate company of Global Napi Pharmaceuticals, founded by Dr. Makram Mehany. Ramco is the agent/importer in Egypt for several multinational pharmaceutical companies, such as Sanofi Aventis and Bayer Health Care. The company provides commercial and promotional support for its customers in addition to outsourcing services for MSD Egypt.

About the Commercial Group of Quintiles

With 10,000 employees in 30 countries, the Commercial group provides innovative, customized commercial solutions to partners throughout the biopharmaceutical industry by leveraging the full suite of Quintiles’ sales, marketing, clinical, consulting and capital services.

About Quintiles

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more than 20,000 engaged professionals in 60 countries works with an unwavering commitment to patients, safety and ethics. Quintiles helps biopharmaceutical companies navigate risk and seize opportunities in an environment where change is constant. For more information, please visit www.quintiles.com.

Contacts

Quintiles
Mari Mansfield, Quintiles Media Relations
+1-919-998-2639
(mari.mansfield@quintiles.com)
or
Greg Connors, Quintiles Investor Relations
+1-919-998-2000
(invest@quintiles.com)